NSCLC
Conditions
Interventions
Sponsors
Beijing Hospital of Traditional Chinese Medicined
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients with primary lung cancer hospitalized in the oncology department of Beijing Traditional Chinese medicine hospital from January 1, 2016 to December 31, 2018 according to the standardized diagnosis and treatment guidelines; (2) The patients were treated with platinum containing double drug chemotherapy for more than 2 cycles; (3) Traditional Chinese medicine injection and Kang'ai injection were used simultaneously in chemotherapy.
Exclusion criteria
Exclusion criteria: At the same time, there are other primary malignant tumors; Lung tumor metastases from other sites to the lung; Pathological diagnosis was small cell lung cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tumor markers; | — |
Secondary
| Measure | Time frame |
|---|---|
| KPS;Overall survival;TCM Syndrome; | — |
Countries
China
Contacts
Public ContactChanghe Sun
Beijing University of Chinese Medicine
Outcome results
None listed